Institute of Laboratory Medicine, Jinling Hospital, Nanjing University School of Medicine, 210002, Nanjing, Jiangsu, China.
Laboratory for Comparative Genomics and Bioinformatics, College of Life Science, Nanjing Normal University, 210046, Nanjing, Jiangsu, China.
Cell Death Dis. 2023 Apr 22;14(4):286. doi: 10.1038/s41419-023-05814-z.
How does SARS-CoV-2 cause lung microenvironment disturbance and inflammatory storm is still obscure. We here performed the single-cell transcriptome sequencing from lung, blood, and bone marrow of two dead COVID-19 patients and detected the cellular communication among them. Our results demonstrated that SARS-CoV-2 infection increase the frequency of cellular communication between alveolar type I cells (AT1) or alveolar type II cells (AT2) and myeloid cells triggering immune activation and inflammation microenvironment and then induce the disorder of fibroblasts, club, and ciliated cells, which may cause increased pulmonary fibrosis and mucus accumulation. Further study showed that the increase of T cells in the lungs may be mainly recruited by myeloid cells through ligands/receptors (e.g., ANXA1/FPR1, C5AR1/RPS19, and CCL5/CCR1). Interestingly, we also found that certain ligands/receptors (e.g., ANXA1/FPR1, CD74/COPA, CXCLs/CXCRs, ALOX5/ALOX5AP, CCL5/CCR1) are significantly activated and shared among lungs, blood and bone marrow of COVID-19 patients, implying that the dysregulation of ligands/receptors may lead to immune cell's activation, migration, and the inflammatory storm in different tissues of COVID-19 patients. Collectively, our study revealed a possible mechanism by which the disorder of cell communication caused by SARS-CoV-2 infection results in the lung inflammatory microenvironment and systemic immune responses across tissues in COVID-19 patients.
SARS-CoV-2 如何引起肺部微环境紊乱和炎症风暴仍不清楚。我们在这里对两名死于 COVID-19 的患者的肺部、血液和骨髓进行了单细胞转录组测序,并检测了它们之间的细胞通讯。我们的结果表明,SARS-CoV-2 感染增加了肺泡 I 型细胞(AT1)或肺泡 II 型细胞(AT2)与髓样细胞之间细胞通讯的频率,触发免疫激活和炎症微环境,进而导致成纤维细胞、Club 细胞和纤毛细胞的紊乱,这可能导致肺纤维化和粘液积聚增加。进一步的研究表明,肺部 T 细胞的增加可能主要是通过髓样细胞通过配体/受体(例如,ANXA1/FPR1、C5AR1/RPS19 和 CCL5/CCR1)招募的。有趣的是,我们还发现某些配体/受体(例如,ANXA1/FPR1、CD74/COPA、CXCLs/CXCRs、ALOX5/ALOX5AP、CCL5/CCR1)在 COVID-19 患者的肺部、血液和骨髓中显著激活并共享,这表明配体/受体的失调可能导致免疫细胞的激活、迁移和 COVID-19 患者不同组织中的炎症风暴。总之,我们的研究揭示了 SARS-CoV-2 感染引起的细胞通讯紊乱导致 COVID-19 患者肺部炎症微环境和跨组织全身免疫反应的可能机制。